Administration

行政

• 批准号: 7287029
• 负责人: David Piwnica-Worms
• 金额: $ 35.19万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-28 至 2011-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7287029
• 关键词: Area; Biological; Clinical Sciences; Collaborations; Commit; Development; Division of Clinical Sciences; Facility Construction Funding Category; Funding; Genetic; Genomics; Housing; Human; Human Genetics; Image; Institution; Knowledge; Lead; Location; Malignant Neoplasms; Medical center; Molecular and Cellular Biology; Pathway interactions; Patient Care; Prevention; Process; Productivity; Research; Research Personnel; Science; Therapeutic; Translating; Treatment Protocols; Universities; Washington; anticancer research; cancer diagnosis; concept; improved; in vivo; in vivo Cellular and Molecular Imaging Centers; molecular imaging; multidisciplinary; novel; novel diagnostics; programs; success

A.1. Institutional Concept of the Center. We have had remarkable success in developing our ICMIC as the focal point for the development of novel in vivo molecular imaging strategies at Washington University. This has involved reinforcing ongoing collaborations, developing new collaborations and enhancing the productivity of multidisciplinary programs in basic and translational cancer research on campus. The ICMIC has promoted excellence in cancer research by providing a formal process for interdisciplinary interaction. This has not only lead to new information in the cellular and molecular biology of cancer, but also enhanced the pathway toward novel diagnostic and therapeutic regimens. Thus, our NCI-funded Molecular Imaging Center program at Washington University has made documented steps to improve cancer diagnosis, treatment and prevention. One area of institutional impact has been in relation to BioMed 21, an institution-wide strategic research initiative that aims to rapidly translate genomic science into patient care. BioMed 21 has been approved at the highest levels and will reshape the Washington University culture over the next 10 years to rapidly convert the knowledge of the genetic blueprint of human beings into effective, individualized treatments. BioMed 21 establishes three new research units that span both campuses of Washington University: The Center for Genomics and Human Genetics, the Division of Clinical Sciences and importantly, the Center for Biological Imaging. WU has committed to the construction of a 250,000 squarefoot building in the center of the medical campus dedicated to bridge the basic and clinical sciences. The Center for Biological Imaging will be housed in this new building, and our ICMIC program will have a major presence in this initiative, providing the potential to further solidify in one central location our current assembly of dedicated investigators.

A.1。中心的制度概念。 我们在开发ICMIC作为发展的焦点方面取得了巨大的成功 华盛顿大学的新型体内分子成像策略。这涉及加强 正在进行的合作，建立新的合作并提高多学科的生产力 校园基本和转化癌研究计划。 ICMIC促进了卓越 通过为跨学科互动的正式过程提供癌症研究。这不仅导致 癌症细胞和分子生物学中的新信息，但也增强了通往的途径 新颖的诊断和治疗方案。因此，我们的NCI资助的分子成像中心计划 华盛顿大学已经记录了改善癌症诊断，治疗和 预防。 机构影响的一个领域与生物疾病有关21，这是一个机构范围的战略 旨在快速将基因组科学转化为患者护理的研究计划。生物21是 获得最高级别的批准，并将在接下来的10年中重塑华盛顿大学的文化 迅速将人类遗传蓝图的知识转化为有效的个性化 治疗。 Biomed 21建立了三个新的研究单元，这些单元跨越了华盛顿的两个校园 大学：基因组学和人类遗传学中心，临床科学和 重要的是，生物成像中心。吴已承诺建造250,000平方英尺 建造在医疗校园的中心，致力于弥合基础科学和临床科学。这 生物成像中心将安置在这座新建筑中，我们的ICMIC计划将有一个主要 这项倡议的存在，提供了进一步巩固我们当前的一个中心位置的潜力 专门的调查员集会。